NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma

Kristen L Baugnon

doi:10.1016/j.nic.2021.08.003

NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma

Neuroimaging Clin N Am. 2022 Feb;32(1):1-18. doi: 10.1016/j.nic.2021.08.003.

Author

Kristen L Baugnon¹

Affiliation

¹ Department of Radiology and Imaging Sciences, Division of Neuroradiology, Head and Neck Imaging, Emory University, 1364 Clifton Road, Atlanta, GA 30322, USA. Electronic address: kmlloyd@emory.edu.

PMID: 34809832
DOI: 10.1016/j.nic.2021.08.003

Abstract

American College of Radiology NI-RADS is a surveillance imaging template used to predict residual or recurrent tumor in the setting of head and neck cancer. The lexicon and imaging template provides a framework to standardize the interpretations and communications with referring physicians and provides linked management recommendations, which add value in patient care. Studies have shown reasonable interreader agreement and excellent discriminatory power among the different NI-RADS categories. This article reviews the literature associated with NI-RADS and serves as a practical guide for radiologists interested in using the NI-RADS surveillance template at their institution, highlighting frequently encountered pearls and pitfalls.

Keywords: Head and neck cancer; Head and neck squamous cell carcinoma; NI-RADS; Surveillance.

Publication types

Review

MeSH terms

Diagnostic Imaging
Diagnostic Tests, Routine
Head and Neck Neoplasms* / diagnostic imaging
Humans
Magnetic Resonance Imaging
Radiologists
Squamous Cell Carcinoma of Head and Neck / diagnostic imaging